{"title":"Synergistic Effect of Topographical Cue and Local Drug Delivery: An Axially-Aligned AM80-Loaded Graft for Preventing Intimal Hyperplasia in Small-Diameter Vascular Grafts","authors":"Fubang Liang, Xinyi Li, Fengqing Yin, Dawei Jin, Xiumei Mo, Meng Yin","doi":"10.1016/j.smaim.2026.06.002","DOIUrl":"https://doi.org/10.1016/j.smaim.2026.06.002","url":null,"abstract":"Small-diameter vascular grafts (SDVGs) continue to present significant clinical challenges due to their poor long-term patency, which primarily results from incomplete endothelialization and intimal hyperplasia (IH). Inspired by the structure of natural blood vessels, this study developed a bilayered electrospun vascular graft. The inner layer consisted of axially aligned poly(L-lactide-co-ε-caprolactone) (PLCL)/silk fibroin (SF) nanofibers designed to guide the alignment and elongation of endothelial cells (ECs), thereby mimicking the natural endothelial architecture. The outer layer was composed of non-aligned PLCL/SF fibers incorporating mesoporous silica nanoparticles (MSNs) loaded with tamibarotene (AM80), a selective retinoic acid receptor α (RARα) agonist. The graft exhibited an aligned microstructure, excellent mechanical properties, and favorable compliance. In vitro studies demonstrated that AM80, at certain concentrations, selectively inhibited the proliferation and migration of vascular smooth muscle cells (VSMCs). Transcriptomic analysis further revealed that AM80 exerted its inhibitory effect on VSMCs by regulating the cell cycle. In vivo evaluation in a rat abdominal aorta implantation model confirmed that, compared to the control group, the graft showed superior patency at 1 and 3 months, accompanied by functional maturation of ECs, absence of significant intimal thickening, and favorable vascular remodeling. In summary, this bilayered graft integrates biomimetic structural design with sustained drug release to achieve long-term patency and offers a promising strategy for next-generation SDVG development.","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148394255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ye Feng , Hai Huang , Dongdong Zhang , Zhaoyu Li , Feng Peng , Huihui Du , Xuanchen Liu , Lan Chen , Haobo Pan , Ning Wang , Donghui Wang
{"title":"Functional biomaterials meet osteosarcoma treatment","authors":"Ye Feng , Hai Huang , Dongdong Zhang , Zhaoyu Li , Feng Peng , Huihui Du , Xuanchen Liu , Lan Chen , Haobo Pan , Ning Wang , Donghui Wang","doi":"10.1016/j.smaim.2026.04.005","DOIUrl":"10.1016/j.smaim.2026.04.005","url":null,"abstract":"<div><div>Osteosarcoma (OS) is a highly aggressive primary bone malignancy with high incidences of pulmonary metastasis and mortality, predominantly affecting children and adolescents. Nanotechnology and nanomaterials have shown significant promise in improving OS diagnosis and treatment. They offer innovative solutions for targeted drug delivery, photothermal therapy, immunotherapy, and modulation of the tumor microenvironment (TME). Additionally, they can be engineered to specifically target tumor cells, deliver therapeutic agents with high precision, and improve overall treatment efficacy. Functional bone implants are crucial for providing mechanical support, preventing recurrence after surgical resection, and promoting bone regeneration. This comprehensive review provides a detailed overview on the current state of OS treatment, highlighting the critical role of advancements in clinical and material science for improving outcomes. This review systematically encompasses the current status of clinical therapeutic strategies as well as the latest advances in functional nanomaterials and bone implant-based approaches for OS treatment. By integrating recent advances in clinical bone oncology and biomedical engineering, this review introduces an innovative, need-driven narrative framework that systematically maps unmet clinical demands onto the precise design principles of functional materials, thereby offering a comprehensive and multidisciplinary perspective on the key challenges and emerging opportunities in OS therapy. Building on this logic, the proposed conceptual framework further translates these clinically defined requirements into actionable material strategies, providing a rational design blueprint and forward-looking roadmap for next-generation OS therapeutic platforms.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 225-271"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148167850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Meiqi Jin , Wanting Liu , Jun Miao , Lin Tao , Huazhe Yang , Xiaoqian Xu
{"title":"A photothermally catalytic nanocomposite dual-crosslinked hydrogel for all-in-one postoperative osteosarcoma bone repair","authors":"Meiqi Jin , Wanting Liu , Jun Miao , Lin Tao , Huazhe Yang , Xiaoqian Xu","doi":"10.1016/j.smaim.2026.04.002","DOIUrl":"10.1016/j.smaim.2026.04.002","url":null,"abstract":"<div><div>Osteosarcoma is among the most aggressive primary bone malignancies in adolescents. Postoperative reconstruction presents a “dual challenge”: complete eradication of residual tumor tissue is required to minimize recurrence, while maximal preservation of surrounding tissues and functional regeneration of bone defects must be achieved. In this study, biomimetic nano–bone minerals based on Zn<sup>2+</sup>/Ce<sup>3+</sup>-substituted whitlockite (Zn<sup>2+</sup>/Ce<sup>3+</sup>-WH) were integrated into a dual-crosslinked hydrogel scaffold constructed from GelMA and GelDA, yielding a GDWH nanocomposite scaffold for an “all-in-one” postoperative osteosarcoma therapy. Under near-infrared irradiation, GDWH exhibited excellent photothermal performance, enabling pronounced photothermally induced ablation of osteosarcoma cells. Meanwhile, the accelerated redox cycling within GDWH efficiently scavenged excessive reactive oxygen species (ROS), thereby suppressing inflammatory responses and protecting adjacent tissues. Furthermore, under an osteoimmune-regulated microenvironment, the GDWH scaffold markedly enhanced osteogenic differentiation and promoted angiogenesis, consequently accelerating bone regeneration within the defect region. Overall, by integrating the triad of “tumor ablation–tissue protection–regenerative repair” into a single platform, the GDWH dual-crosslinked nanocomposite hydrogel scaffold offers a translationally promising, comprehensive solution for the complex postoperative pathology of osteosarcoma and provides new insights into multimodal synergistic therapeutic strategies for osteosarcoma.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 193-205"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148167974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Csaba Hegedűs, Etelka D. Tóth, Róbert Boda, István Lázár, Andrea Keczánné-Üveges, József Bakó, Ferenc Tóth, György Trencsényi, Ibolya Kálmán-Szabó, Monika Béresová, Zsófi Sajtos, Ádám Deák, Adrienn Tóth, Dóra Horváth, Botond Gaál, Lajos Daróczi, Balázs Dezső, László Ducza, Attila Jenei, József Tőzsér, Edit Hrubi
{"title":"Improved ossification patterns using new vat-polymerized 3D printed hydrogel–bioceramic composites with sustained ion release (Ca, P, Si)","authors":"Csaba Hegedűs, Etelka D. Tóth, Róbert Boda, István Lázár, Andrea Keczánné-Üveges, József Bakó, Ferenc Tóth, György Trencsényi, Ibolya Kálmán-Szabó, Monika Béresová, Zsófi Sajtos, Ádám Deák, Adrienn Tóth, Dóra Horváth, Botond Gaál, Lajos Daróczi, Balázs Dezső, László Ducza, Attila Jenei, József Tőzsér, Edit Hrubi","doi":"10.1016/j.smaim.2026.06.003","DOIUrl":"10.1016/j.smaim.2026.06.003","url":null,"abstract":"<div><div>Bone and bone-deficiency diseases represent a significant clinical challenge, particularly in maxillofacial and orthopedic surgery. Although bone possesses considerable healing capacity, this is insufficient in cases of substantial defects. Various approaches have been proposed, including autograft, allograft, and alloplastic bioactive bone substitutes.</div><div>This study compares MPGA-based 3D-printable hydrogel (HG), β-tricalcium phosphate-filled hydrogel composite (BTCP-HG), and aerogel/BTCP-filled hydrogel (AE/BTCP-HG) scaffolds for <em>in vitro</em> and <em>in vivo</em> investigations.</div><div>The 3D-printed composite hydrogels exhibited Young's modulus values of 0.1028 ± 0.041 MPa for BTCP-HG and 0.3350 ± 0.138 MPa for AE/BTCP-HG, corresponding to an approximately 3.3-fold increase in stiffness for the aerogel-containing composite.</div><div>Reossification and biodegradibilty appeared strongest with BTCP-HG scaffold with histological, imaging, biochemical and semiquantitative assessments, allowing anti-inflammatory microenvironment by early significant drop of CD68<sup>+</sup> macrophages (1st month: 76.5 ± 7.2 vs. 3rd month: 3.25 ± 1.18 cells/section); confirmed also by high alkaline phosphatase activity. AE/BTCP-HG also displayed strong regenerative potential due to Si content, the consequent type I collagen build-up however, remained unmineralized until the 6th month, though subsequently, collagen is critical for hydroxyapatite deposition. Doubled pro-inflammatory CD68<sup>+</sup> macrophages (1st month: 12.12 ± 1.2 vs. 6th month: 27.87 ± 1.87 cells/section) proximal to AE/BTCP-HG also tempts to confirm the promising regenerative potential.</div><div>Our newly developed light-curing, degradable PGA-based hydrogel composite shows promising potential for maxillofacial applications. A key advantage is its rapid digital design capability and compatibility with vat-photopolymerization. Our <em>in vitro</em> and <em>in vivo</em> experiments indicate that BTCP and AE/BTCP bioceramics embedded in hydrogels can facilitate prolonged bone formation through a sustained slow-release mechanism.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 407-421"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148582693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Glucose oxidase-engineered cell membrane vesicles co-delivering CRISPR/Cas9 and croconaine dye for traceable synergistic tumor therapy","authors":"Yifan Zhang, Zechun Dang, Xinlan Lai, Fang Bai, Jing Lin, Jianlin Ge, Peng Huang","doi":"10.1016/j.smaim.2026.09.002","DOIUrl":"10.1016/j.smaim.2026.09.002","url":null,"abstract":"<div><div>Mild photothermal therapy (PTT, <45 °C) minimizes collateral damage to healthy tissues but is frequently compromised by heat shock protein (HSP)-mediated thermal resistance. Herein, we develop a genetically engineered biomimetic nanoplatform, designated as pCas9@GM-Croc (CGMC), to achieve traceable synergistic starvation/gene/photothermal therapy. Glucose oxidase (GOx) is stably expressed on HEK293T cell membranes to fabricate vesicles (GM) that prevent premature enzyme leakage while ensuring robust lysosomal escape. These vesicles deliver clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) plasmids (pCas9) targeting HSP90α and integrate an acid-responsive croconaine dye (Croc) into their lipid bilayers. Mechanistically, GOx-mediated adenosine triphosphate (ATP) depletion acts in tandem with pCas9 genome editing to decrease HSP90α expression, profoundly impairing the thermal tolerance of tumor cells. Concurrently, GOx-catalyzed gluconic acid generation activates the fluorescence (FL) and photoacoustic (PA) signals of Croc, enabling real-time, non-invasive monitoring of therapeutic progression and tumor deoxygenation. Both in vitro and in vivo results demonstrate that CGMC exhibits high tumor accumulation and remarkable synergistic antitumor efficacy, achieving nearly complete tumor suppression under 808 nm laser irradiation with favorable biocompatibility. This work provides an imaging-traceable biomimetic strategy to overcome thermal endurance for enhanced tumor treatment.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 514-522"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149211373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Binqian Zhou , Yunxiang Zhang , Qian Lei , Zhitao Zhang , Rui Wang , Peizhao Liu , Xiaoqian Xu , Tingting Jia , Jiaji Cheng
{"title":"Chiral noble-metal nanomaterials: Chiral origins and biomedical applications","authors":"Binqian Zhou , Yunxiang Zhang , Qian Lei , Zhitao Zhang , Rui Wang , Peizhao Liu , Xiaoqian Xu , Tingting Jia , Jiaji Cheng","doi":"10.1016/j.smaim.2026.01.001","DOIUrl":"10.1016/j.smaim.2026.01.001","url":null,"abstract":"<div><div>Chirality is a fundamental property in nature, and the rapid progress of nanoscience has enabled the design and fabrication of nanoscale materials with precisely controlled chiral architectures. These chiral nanostructures exhibit unique optical, catalytic, and sensing characteristics. Among them, chiral noble-metal nanomaterials owing to their intrinsic localized surface plasmon resonance, catalytic activity, and biocompatibility, show tremendous application potential in the biomedical field. This review provides a comprehensive overview of chiral noble-metal nanomaterials. We first summarize their chiroptical properties and discuss the structural origins of chirality at the molecular, nanoscale, and nano-/micro-size. We then highlight biomedical applications, including biosensing, enantioselective separation, antibacterial applications, neurodegenerative diseases and cancer diagnosis and therapy. Finally, we discuss the key challenges that must be addressed, including the precise and reproducible fabrication of chiral nanostructures, unresolved biosafety concerns, and an incomplete mechanistic understanding at the molecular and cellular levels. We anticipate that, by overcoming these challenges, chiral noble-metal nanomaterials will assume increasingly impactful roles in biomedicine.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 59-76"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A review on the auxetic materials and their applications in biomedical engineering","authors":"Qiang Gao, Yang Zhou, Zhou Li","doi":"10.1016/j.smaim.2026.09.001","DOIUrl":"10.1016/j.smaim.2026.09.001","url":null,"abstract":"<div><div>Over the past decade, auxetic materials have garnered significant attention due to their unconventional mechanical characteristics. Researchers have proposed multitudinous auxetic materials with improved mechanical properties by designing their core microcells. These advanced auxetic materials exhibit broad application prospects in fields such as transportation, civil engineering, aerospace, biomedical engineering, etc. This review focuses on the latest progress of auxetic materials in the biomedical field. The basic types, improvements, and mechanical properties of auxetic materials are introduced first. Then, the applications of auxetic materials in biomedical engineering are systematically reviewed, including stents, bone implants, tissue engineering, organ patches, and biomedical sensors. It can be summarized that auxetic materials have provided significant support for biomedical engineering from structural mechanics and biomechanics. Finally, several future outlooks for utilizing auxetic materials in biomedical engineering are discussed to promote the further development of auxetic biomedical devices.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 494-513"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149051093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alap Ali Zahid, Jiaqi Huang, Reza Noroozi, HaoTian Harvey Shi, Nica Borradaile, Arghya Paul
{"title":"Lactoferrin-functionalized RBC membrane-derived nanoparticles for targeted drug delivery: Implications in steatotic liver disease therapy","authors":"Alap Ali Zahid, Jiaqi Huang, Reza Noroozi, HaoTian Harvey Shi, Nica Borradaile, Arghya Paul","doi":"10.1016/j.smaim.2026.10.003","DOIUrl":"10.1016/j.smaim.2026.10.003","url":null,"abstract":"<div><div>Metabolic dysfunction-associated steatotic liver disease (MASLD) is marked by excessive hepatic lipid accumulation and is closely associated with hyperlipidemia. It poses significant health challenges and can progress to severe chronic liver disease if untreated. Several small-molecule pharmacological agents are either in clinical use (resmetirom) or advancing through preclinical development for the treatment of hepatic steatosis. However, some promising lead drug candidates have limited therapeutic potential due to poor solubility, low permeability, limited biocompatibility, and off-target effects. Cell membrane-derived nanoparticles (CMN), prepared from red blood cells, naturally exhibit immune-evasion properties and can overcome these limitations by encapsulating small molecules within their self-assembled structures. Further, CMN can be surface functionalized to enable precise targeting of liver hepatocytes. Here, we developed a hepatocyte-targeting CMN loaded with a model drug (resmetirom) for MASLD therapy. Three hepatocyte-targeting ligands were covalently conjugated to CMN and comparatively evaluated <em>in vitro</em>, identifying lactoferrin (Lf) as the most effective ligand for hepatocyte targeting, providing a 3.4-fold increase in uptake efficiency compared to CMN. In a physiologically relevant microfluidic model, CMN-Lf showed a 7.2-fold increase in fluorescence intensity compared with non-targeted CMN, indicative of improved hepatocyte targeting. Finally, in an <em>in vitro</em> hepatic steatosis model, the optimized targeted CMN demonstrated improved bioactivity, including significant reductions in lipid droplets, triglycerides (18.5 ± 7.1% decreased compared with the negative control), and liver enzyme levels. Altogether, this Lf-functionalized CMN nanoplatform offers strong transformative solutions by leveraging its inherent biocompatibility and ability to facilitate targeted drug delivery MASLD therapy, and other potential liver diseases.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 523-535"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149361043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ying Zhang , Meixian Jin , Liqin Chen , Yingqi Zhou , Kexin Wang , Xucheng Li , Li Zhang , Songxia Zhou , Xiuli Zhong , Xiaojuan Zhu , Qing Peng , Zhaoting Li , Shuqin Zhou
{"title":"Harnessing extracellular matrix hydrogel for synergistic neurorehabilitation in traumatic brain injury","authors":"Ying Zhang , Meixian Jin , Liqin Chen , Yingqi Zhou , Kexin Wang , Xucheng Li , Li Zhang , Songxia Zhou , Xiuli Zhong , Xiaojuan Zhu , Qing Peng , Zhaoting Li , Shuqin Zhou","doi":"10.1016/j.smaim.2026.05.002","DOIUrl":"10.1016/j.smaim.2026.05.002","url":null,"abstract":"<div><div>Traumatic brain injury (TBI) is characterized by neuronal loss, vascular disruption, and limited regenerative capacity, further exacerbated by the absence of a supportive extracellular matrix (ECM) within lesion cavities. Here, an injectable, photo-crosslinkable ECM-based hydrogel (ECMMA/BDNF/SCS) is developed to remodel the post-injury microenvironment and promote neural repair. The hydrogel is derived from decellularized porcine ECM modified with methacrylate groups and incorporated with sulfonated chitosan (SCS) and mesoporous silica nanoparticles for sustained delivery of brain-derived neurotrophic factor (BDNF).</div><div>The ECMMA/BDNF/SCS hydrogel exhibits tunable mechanical properties matching native brain tissue and enables controlled BDNF release. In vitro, it shows good biocompatibility, promotes endothelial cell migration and tube formation, and directs neural stem cell differentiation toward neuronal lineage, as indicated by increased β-III Tubulin (Tuj1) and decreased GFAP expression. In a rat TBI model, hydrogel implantation reduces lesion volume, enhances vascularization and neurogenesis, and improves sensorimotor and cognitive function.</div><div>At the molecular level, these effects are associated with reduced neuronal apoptosis and modulation of PI3K/ERK and STAT3 signaling pathways. Overall, this multifunctional ECM-based hydrogel provides structural and biochemical cues to facilitate neurovascular regeneration, highlighting its potential for TBI therapy.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 272-286"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148230580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jie Men , Qianru Guo , Junfeng Cao , Jinyu Yu , Lianghao Jia , Yufei Yong , Tao Xiang , Kezhou Li
{"title":"Gastrodin-encapsulated injectable hyaluronic acid hydrogel promotes volumetric muscle loss repair via myogenesis","authors":"Jie Men , Qianru Guo , Junfeng Cao , Jinyu Yu , Lianghao Jia , Yufei Yong , Tao Xiang , Kezhou Li","doi":"10.1016/j.smaim.2026.05.005","DOIUrl":"10.1016/j.smaim.2026.05.005","url":null,"abstract":"<div><div>Volumetric muscle loss (VML) induces irreversible functional impairment, characterized by extensive loss of muscle mass and failure of endogenous regenerative mechanisms. Current tissue engineering strategies are often limited by inadequate mechanical integration with native tissue and an inability to counteract the hostile microenvironment, thereby hindering effective myogenesis. Herein, we developed a multifunctional hyaluronic acid hydrogel (HPAu@Gas) based on <em>in situ</em> Suzuki-Miyaura coupling reaction, which incorporates the bioactive molecule Gastrodin (Gas). The hydrogel exhibits excellent adaptability to irregular defects and enables sustained local delivery of Gas. Transcriptomic sequencing and molecular analyses suggested that Gas promoted myoblast activity partly through chemokine-related signaling and subsequent activation of the JAK-STAT cascade <em>in vitro</em>. This signaling axis enhances myoblast survival, proliferation, and migration, thereby counteracting the hostile microenvironment characteristic of VML. In rat tibialis anterior VML model, HPAu@Gas markedly improved hindlimb grip strength at day 14, reaching 1.14 N compared with 0.65 N in the untreated VML group and approaching the uninjured level of 1.19 N. Histologically, HPAu@Gas increased regenerated muscle fiber area to 70.8% and reduced fibrotic area to 12.1% at day 14. EMG analysis further showed substantial restoration of electrophysiological activity. These results validate the injectable self-healing hydrogels as novel scaffolds for VML treatment and skeletal muscle regeneration.</div></div>","PeriodicalId":22019,"journal":{"name":"Smart Materials in Medicine","volume":"7 ","pages":"Pages 287-300"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148230581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}